Autres langues Atomo Diagnostics Limited

Actions

AT1

AU0000080327

Marché Fermé - Australian S.E. Autres places de cotation 08:10:46 10/05/2024			Varia. 5j.	Varia. 1 janv.
0,027 ^AUD	-3,57%		-10,00%	+22,73%

30/04	Transcript : Atomo Diagnostics Limited, Q3 2024 Earnings Call, Apr 30, 2024
06/03	Atomo Diagnostics obtient une commande de 970 000 dollars australiens pour la fourniture d'autotests de dépistage du VIH	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Atomo Diagnostics Wins AU$570,000 HIV Self-Tests Order	15/04
Atomo Diagnostics Wins Order to Supply AU$970,000 Worth of HIV Self-Tests	06/03
Atomo Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	25/02
Atomo Diagnostics Limited Announces the Resignation of Curt LaBelle as Non-Executive Director	19/12
Actinogen Medical Names CFO	08/11
Atomo Diagnostics CFO to Step Down	07/11
Atomo Diagnostics Limited Announces the Departure of William Souter as Chief Financial Officer, Effective 13 December 2023	06/11
Atomo Diagnostics Expands Footprint of HIV Self-Test Kit	20/10/23
Seattle-based startup makes 'beanless coffee' to help combat deforestation	04/10/23
Atomo Diagnostics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	24/08/23
Atomo Diagnostics Raises AU$2.3 Million Via Placement, Share Purchase Plan	08/08/23
Atomo Diagnostics Raising AU$4 Million Via Placement, Share Purchase Plan	13/07/23
Atomo Diagnostics Signs Deal to Supply HIV Tests to Europe	14/06/23
Atomo Diagnostics Secures Nearly $2 Million Supply Deal for HIV Self-Test in South Africa	05/04/23
Atomo Diagnostics Secures AU$900,000 HIV Self-Tests Order	28/02/23
Atomo Diagnostics Limited Announces Significant Purchase Order for HIV Self-Tests for Europe	27/02/23
Atomo Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	22/02/23
Atomo Diagnostics Limited Announces Change of Company Secretary, Effective March 1, 2023	22/02/23
Atomo Diagnostics, NG Biotech Sign Commercialization Deal for Rapid Blood-based Pregnancy Tests; Shares Jump 4%	18/01/23
Atomo Diagnostics Limited and NG Biotech Sign New Commercialisation Agreement to Expand the Launch of A Unique Blood Based Rapid Pregnancy Test in Key Global Markets	17/01/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Atomo Diagnostics Limited

Actions

AT1

AU0000080327

Autres langues

Filtres